29 September 2010 /Product areas
On 8 April 2010, the Danish Medicines Agency warned against the use of breast implants pre-filled with silicone based gel labelled IMGHC-TX, IMGHC-MX or IMGHC-LS manufactured by the French company Poly Implant Prothèse.
24 September 2010 /Side effects and trials
The Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has reviewed the benefits and risks of rosiglitazone-containing medicines (Avandia, Avandamet and Avaglim) used in diabetes care.
23 September 2010 /About us
A business visit to Shanghai and Beijing in September has strengthened collaboration between the Danish Medicins Agency and its Chinese counterpart, SFDA.
22 September 2010 /Side effects and trials
Based on increased reports of blood clots from the use of Octagam® 50 mg/ml in 2010, the Danish Medicines Agency has decided to recall Octagam® in Denmark. Octagam® is available in two strengths (50 mg/ml and 100 mg/ml) both of which are recalled.
15 September 2010 /Side effects and trials
In week 37 the Danish Medicines Agency launches a nationwide campaign, setting out to encourage hospital doctors to be more active in reporting serious and unexpected side effects from medicine. The Danish Medicines Agency runs this campaign because it estimates that whenever one side effect is reported by a hospital doctor another 50 serious or unexpected side effects go unreported.
15 September 2010 /News - miscellaneous
Illegal medicines under the counter, unauthorised sale of food supplements in the back? Next week, the Danish Veterinary and Food Administration and the Danish Medicines Agency concentrate their efforts to combat the distribution of illegal food supplements and medicines in fitness centres and fitness clubs across Denmark.
02 September 2010 /Product areas
On 29 August, DR TV (Danish Broadcasting Corporation) broadcast a story on the Danish company Oversea Labs about gold dental crowns.